Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05069415 · ClinicalTrials.gov registry record · NA
Monofocal IOL Visual Outcomes When Targeting Mini Monovision
A NA study of Cataract and Presbyopia, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT05069415: Completed NA study of Cataract and Presbyopia, sponsored by Carolina Eyecare Physicians.
NCT05069415 is a NA study of Cataract and Presbyopia that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 75 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05069415, a NA study of Cataract and Presbyopia, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a 3-month, prospective, up to 2 center, bilateral, randomized subject masked clinical evaluation of a monofocal intraocular lens (IOL) when both eyes are targeted for emmetropia and when the non-dominant eye is targeted for mini monovision (-0.75 D) in patients with or without astigmatism undergoing routine cataract surgery.
Conditions Studied
Interventions
- DEVICE Eyhance IOL
Study Locations (2)
Florida
- Center for Sight - Sarasota
South Carolina
- Carolina Eyecare Physicians, LLC - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT05069415 record still lists
NCT05069415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Eyhance IOL is the first listed.
NCT05069415 reports a single indexed study location in Florida, South Carolina.
Frequently Asked Questions
What is clinical trial NCT05069415 about?
NCT05069415 is a clinical study titled "Monofocal IOL Visual Outcomes When Targeting Mini Monovision". This study is a 3-month, prospective, up to 2 center, bilateral, randomized subject masked clinical evaluation of a monofocal intraocular lens (IOL) when both eyes are targeted for emmetropia and when the non-dominant eye is targeted for mini monovision (-0.75 D) in patients with or without astigmat...
What is the current status of trial NCT05069415?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-10-04. Estimated completion is 2022-11-30.
What conditions does trial NCT05069415 study?
This clinical trial studies the following conditions: Cataract, Presbyopia.
What interventions are being tested in trial NCT05069415?
The interventions under investigation include: Eyhance IOL (DEVICE).
Who is sponsoring clinical trial NCT05069415?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05069415 being conducted?
This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05069415's enrollment target sits among peer trials
75 46th of 83 higher than 38 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI